IBEX (IBEX) Competitors $24.98 -0.17 (-0.68%) Closing price 04:00 PM EasternExtended Trading$23.56 -1.43 (-5.70%) As of 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IBEX vs. NEO, DFIN, NVEE, FLYW, TASK, CTOS, EVH, PSFE, OLO, and RDWRShould you be buying IBEX stock or one of its competitors? The main competitors of IBEX include NeoGenomics (NEO), Donnelley Financial Solutions (DFIN), NV5 Global (NVEE), Flywire (FLYW), TaskUs (TASK), Custom Truck One Source (CTOS), Evolent Health (EVH), Paysafe (PSFE), OLO (OLO), and Radware (RDWR). These companies are all part of the "business services" industry. IBEX vs. NeoGenomics Donnelley Financial Solutions NV5 Global Flywire TaskUs Custom Truck One Source Evolent Health Paysafe OLO Radware IBEX (NASDAQ:IBEX) and NeoGenomics (NASDAQ:NEO) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, community ranking, earnings, analyst recommendations and dividends. Do insiders and institutionals hold more shares of IBEX or NEO? 81.2% of IBEX shares are held by institutional investors. Comparatively, 98.5% of NeoGenomics shares are held by institutional investors. 6.7% of IBEX shares are held by insiders. Comparatively, 1.3% of NeoGenomics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has stronger valuation & earnings, IBEX or NEO? IBEX has higher earnings, but lower revenue than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than IBEX, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIBEX$521.73M0.63$33.65M$2.1311.70NeoGenomics$660.57M1.84-$87.97M-$0.62-15.26 Do analysts rate IBEX or NEO? IBEX presently has a consensus target price of $25.00, suggesting a potential upside of 0.32%. NeoGenomics has a consensus target price of $19.60, suggesting a potential upside of 107.19%. Given NeoGenomics' stronger consensus rating and higher possible upside, analysts clearly believe NeoGenomics is more favorable than IBEX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IBEX 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50NeoGenomics 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.80 Does the MarketBeat Community believe in IBEX or NEO? NeoGenomics received 474 more outperform votes than IBEX when rated by MarketBeat users. Likewise, 70.81% of users gave NeoGenomics an outperform vote while only 41.77% of users gave IBEX an outperform vote. CompanyUnderperformOutperformIBEXOutperform Votes3341.77% Underperform Votes4658.23% NeoGenomicsOutperform Votes50770.81% Underperform Votes20929.19% Is IBEX or NEO more profitable? IBEX has a net margin of 7.08% compared to NeoGenomics' net margin of -11.92%. IBEX's return on equity of 25.29% beat NeoGenomics' return on equity.Company Net Margins Return on Equity Return on Assets IBEX7.08% 25.29% 13.16% NeoGenomics -11.92%-2.10%-1.17% Which has more risk & volatility, IBEX or NEO? IBEX has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500. Comparatively, NeoGenomics has a beta of 1.28, meaning that its share price is 28% more volatile than the S&P 500. Does the media refer more to IBEX or NEO? In the previous week, IBEX had 9 more articles in the media than NeoGenomics. MarketBeat recorded 17 mentions for IBEX and 8 mentions for NeoGenomics. NeoGenomics' average media sentiment score of 0.40 beat IBEX's score of 0.17 indicating that NeoGenomics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IBEX 2 Very Positive mention(s) 1 Positive mention(s) 13 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NeoGenomics 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryNeoGenomics beats IBEX on 10 of the 18 factors compared between the two stocks. Remove Ads Get IBEX News Delivered to You Automatically Sign up to receive the latest news and ratings for IBEX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IBEX vs. The Competition Export to ExcelMetricIBEXData processing & preparation IndustryBusiness SectorNASDAQ ExchangeMarket Cap$328.75M$3.90B$7.15B$7.90BDividend YieldN/A3.85%2.53%4.04%P/E Ratio11.7065.3330.0618.77Price / Sales0.63659.02149.7188.53Price / Cash8.0833.7431.4034.64Price / Book3.026.054.754.17Net Income$33.65M$42.75M$194.26M$247.10M7 Day Performance-1.39%-3.70%-3.07%-3.12%1 Month Performance-1.54%-7.27%-5.01%-6.63%1 Year Performance72.94%5.87%4.73%0.05% IBEX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IBEXIBEX1.1872 of 5 stars$24.98-0.7%$25.00+0.1%+67.7%$329.54M$521.73M11.7330,000Short Interest ↑News CoverageNEONeoGenomics3.4239 of 5 stars$10.16+3.0%$19.60+92.9%-39.2%$1.31B$660.57M-16.392,100Short Interest ↑News CoverageDFINDonnelley Financial Solutions3.6845 of 5 stars$45.56+2.2%$71.33+56.6%-29.2%$1.30B$781.90M14.892,150Positive NewsNVEENV5 Global3.1323 of 5 stars$19.37+3.6%$25.67+32.5%-19.6%$1.26B$941.27M39.333,640Positive NewsFLYWFlywire3.9354 of 5 stars$10.06+1.0%$18.23+81.2%-59.6%$1.24B$492.14M67.07660Analyst ForecastShort Interest ↑High Trading VolumeTASKTaskUs2.6986 of 5 stars$13.61+1.7%$17.86+31.2%+18.6%$1.22B$994.99M23.0749,500CTOSCustom Truck One Source2.7854 of 5 stars$5.15+7.4%$5.88+14.2%-28.7%$1.16B$1.80B-32.162,580EVHEvolent Health2.8822 of 5 stars$9.69+1.1%$17.71+82.9%-69.8%$1.13B$2.55B-11.815,100PSFEPaysafe1.1588 of 5 stars$17.96+3.6%$17.88-0.4%+2.9%$1.09B$1.70B-47.253,500Short Interest ↑News CoverageGap DownOLOOLO3.3629 of 5 stars$6.54+1.6%$8.67+32.5%+15.2%$1.09B$284.94M-65.42710RDWRRadware2.6632 of 5 stars$22.96-0.1%$30.00+30.7%+15.3%$964.21M$274.88M164.011,140Analyst Forecast Remove Ads Related Companies and Tools Related Companies NEO Competitors DFIN Competitors NVEE Competitors FLYW Competitors TASK Competitors CTOS Competitors EVH Competitors PSFE Competitors OLO Competitors RDWR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IBEX) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IBEX Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share IBEX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IBEX Stock Free IBEX Stock Alerts